From a Different Way | GenomeWeb

From a Different Way

While personalized medicine promises more individualized treatments, Janet Woodcock, director of the US Food and Drug Administration's Center for Drug Evaluation and Research, says that clinical trials have to change to be able to study such drugs that are effective only in small numbers of patients, reports the PharmExecBlog.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Trends to Watch

Mish Mash of Cells

FDA Approved

Biopsy Troubles

Room to Grow

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.